Polypharmacy in maintenance of bipolar disorder

Clinical Neuropharmacology

Volumn 39, Issue 3, 2016, Pages 132-134

  Peselow, Eric D ^a   Naghdechi, Lancer ^b   Pizano, Demetria ^a   IsHak, Waguih William ^c,d  

^a Freedom from Fear   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar disorder; Long term follow up,maintenance treatment; Polypharmacy

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROIC ACID; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; MONOTHERAPY; MOOD; POLYPHARMACY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; TREATMENT RESPONSE; ADOLESCENT; AGED; BIPOLAR DISORDER; COMBINATION DRUG THERAPY; LONGITUDINAL STUDY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; SECONDARY PREVENTION; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84961221638     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0000000000000147     Document Type: Article

References (18)

1. Solomon DA, Keitner GI, Ryan CE, et al. Polypharmacy in bipolar I disorder. Psychopharmacol Bull 1996;32(4):579-87.
2. Gitlin MJ, Swendsen J, Heller TL, et al. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995;152:1635.
3. Goldberg JF, Harrow M, Sands JR. Lithium and the longitudinal course of bipolar illness. Psychiatr Ann 1996;26:651-658.
4. Levine J, Chengappa KN, Brar JS, et al. Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord 2000;2: 120-130.
5. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH Life Chart Method. J Clin Psychiatry 2003;64:680-690.
6. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39: 713-720.
7. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-782.
8. American Psychiatric Association. DSM-III. Diagnostic and Statistical Manual for Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
9. American Psychiatric Association. DSM-III-R. Diagnostic and Statistical Manual for Mental Disorders. 3rd ed, Revised. Washington, DC: American Psychiatric Association; 1987.
10. American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual for Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
11. Angst J. The course of affective disorders, II: typology of bipolar manic-depressive illness. Arch Psychiatr Nervenkr 1978:22665-73.
12. Solomon DA, Keitner GI, Ryan CE, et al. Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review. J Clin Psychopharmacol 1998;18(1):55-61.
13. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005;162:2152-2161.
14. Baethge C, Baldessarini R, Mathiske-Schmidt K, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry 2005;66(02):174-182.
15. Yatham L. Monotherapy is not as good as polypharmacy for BD. Can J Psychiatry 2009;54(11):721-723.
16. Orne M. On the social psychology of the psychological experiment: with particular reference to demand characteristics and their implications. Am Psychol 1962;17(11):776-783.
17. Rosenberg M. When dissonance fails: on eliminating evaluation apprehension from attitude measurement. J Pers Soc Psychol 1965;1(1):28-42.
18. Post RM, Speer AM, Leverich GS. Complex combination therapy: the evolution toward rational polypharmacy in lithium-resistant bipolar illness. In: Akiskal HS, Tohen M, eds. Bipolar Psychopharmacotherapy: Caring for the Patient. London, UK: John Wiley & Sons Ltd; 2006:135-167.